Evidence map›Paper›PMID 33014110›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Effect of Moxibustion on the Serum Levels of MMP-1, MMP-3, and VEGF in Patients with Rheumatoid Arthritis.

Zeyun Yu, Yingni Wang, Yuan Li, Chenxi Liao, Jingyang Dai, Yun Luo, Yuanzhang Hu, Siyu Tao, Jie Tang, Guanhua Chen and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Comparative analysis ofFrontiers in pharmacology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zeyun YuChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Yingni WangChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Yuan LiHospital of Chengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Chenxi LiaoChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Jingyang DaiChengdu Fifth People' Hospital, Chengdu 611130, China.
Yun LuoChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Yuanzhang HuChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Siyu TaoChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Jie TangChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Guanhua ChenChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Ping WuChengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.ORCID https://orcid.org/0000-0003-4062-9447
Chengdu University of Traditional Chinese Medicine · CNChengdu Fifth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, which will eventually lead to joints deformity and functional damage. The aim of this research is to evaluate the effect of moxibustion on the serum indicators related to bone and cartilage metabolism, matrix metalloproteinase 1 (MMP-1), matrix metalloproteinase 3 (MMP-3), and vascular endothelial growth factor (VEGF) in patients with RA and to explore the mechanism of moxibustion in the treatment of RA.

methodsWe recruited 70 RA patients who met the inclusion criteria, and they were randomly divided into two groups, a treatment group and a control group in equal ratio. The control group took methotrexate, folate, or leflunomide orally, while the treatment group received methotrexate, folate, or leflunomide orally and moxibustion at ST36 (Zusanli), BL23 (Shen shu), and Ashi points. We compared the clinical symptoms, RA serological disease markers and serum contents of interleukin-1

results(1) The clinical symptoms and RA serological disease markers of the two groups improved after treatment (

conclusionThe improvement effect of moxibustion on the clinical symptoms of RA patients may be related to influence on the contents of IL-1

Identifiers

PMID33014110
PMCPMC7519456
OpenAlexW3087071724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.